Cargando…
Atopic dermatitis treated with tralokinumab and upadacitinib combination therapy: A case report
A patient presented to clinic with atopic dermatitis that had been previously unresponsive to multiple topical and systemic therapies. They were successfully treated with a combination of tralokinumab and upadacitinib, showing significant improvement after 3 weeks and near-resolution after 6 months.
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291146/ https://www.ncbi.nlm.nih.gov/pubmed/37377458 http://dx.doi.org/10.1177/2050313X231180766 |